Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variants.

doi:10.1016/j.parkreldis.2024.107041

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variants.

Parkinsonism & related disorders - 1 Sept 2024

Nance Martha, Phillips Oliver, Tropea Thomas F

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Testing
Share to Glucosylceramidase
Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Parkinson Disease

Share to Prodromal Symptoms

Source

Open in PubMed

Identifiers

PMID: 38964951
DOI: 10.1016/j.parkreldis.2024.107041

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Hope vs. Hype II: It is time to offer pre-symptomatic genetic testing for GBA and LRRK2 variants.PMID 38964951Read ↗

Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test SelectionSemantic proximity Read ↗

Patients' Perspectives on Psychiatric Pharmacogenetic Testing.Semantic proximity Read ↗

Lack of Association of Generic Brittle Status with Genetics and Physiologic Measures in Patients with Epilepsy.Semantic proximity Read ↗

Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed HackathonSemantic proximity Read ↗

Patients with rare diseases: from therapeutic orphans to pioneers of personalized treatments.Semantic proximity Read ↗

Driving genotype treatment options down the right path(way).Semantic proximity Read ↗

Quantifying hope: An EU perspective of rare disease therapeutic space and market dynamicsSemantic proximity Read ↗

From diagnosis to treatment in genetic epilepsies: Implementation of precision medicine in real-world clinical practiceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.